BWAY Key Statistics, Chart & Performance
The current stock price of BWAY is 20.93 USD. In the past month the price decreased by -5.34%. In the past year, price increased by 104%.
BWAY Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 95.67% of all stocks.
BWAY Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BWAY. While BWAY has a great health rating, its profitability is only average at the moment.
BWAY Financial Highlights
Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS increased by 260.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.73% | ||
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.08 |
BWAY Forecast & Estimates
7 analysts have analysed BWAY and the average price target is 0.12 USD. This implies a price decrease of -99.42% is expected in the next year compared to the current price of 20.93.
For the next year, analysts expect an EPS growth of 77.47% and a revenue growth 13.72% for BWAY
BWAY Ownership
BWAY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.02 | 188.146B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.95 | 169.625B | ||
| SYK | STRYKER CORP | 23.97 | 137.924B | ||
| BSX | BOSTON SCIENTIFIC CORP | 22.17 | 111.924B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 59.33B | ||
| IDXX | IDEXX LABORATORIES INC | 43.44 | 51.339B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.38 | 46.291B | ||
| RMD | RESMED INC | 21.75 | 38.394B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.39 | 37.64B | ||
| DXCM | DEXCOM INC | 27.76 | 27.621B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BWAY
Company Profile
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Company Info
BRAINSWAY LTD-ADR
16 Hartum Street Rad Tower, 14Th Floor, Har HaHotzvim
JERUSALEM 9777518 IL
CEO: Christopher R. von Jako
Employees: 120
Phone: 97225813140
BRAINSWAY LTD-ADR / BWAY FAQ
What does BWAY do?
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Can you provide the latest stock price for BRAINSWAY LTD-ADR?
The current stock price of BWAY is 20.93 USD. The price decreased by -5.49% in the last trading session.
Does BRAINSWAY LTD-ADR pay dividends?
BWAY does not pay a dividend.
What is the ChartMill rating of BRAINSWAY LTD-ADR stock?
BWAY has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is BRAINSWAY LTD-ADR (BWAY) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BWAY.
What is the next earnings date for BWAY stock?
BRAINSWAY LTD-ADR (BWAY) will report earnings on 2026-03-09, before the market open.
What is the outstanding short interest for BRAINSWAY LTD-ADR?
The outstanding short interest for BRAINSWAY LTD-ADR (BWAY) is 0.8% of its float.